AIA On-Sale Bar At The High Court: What You Need To Know

Law360 (December 3, 2018, 6:27 PM EST) -- The U.S. Supreme Court will hear arguments Tuesday on whether the America Invents Act narrowed the on-sale bar in patent cases, tackling a question that has lingered since the law was enacted more than seven years ago.

The case was brought to the Supreme Court by Helsinn Healthcare SA, which saw its patent on the nausea drug Aloxi invalidated by the Federal Circuit last year amid an infringement dispute with Teva Pharmaceuticals USA Inc.

Here's a look at what you need to know about the closely watched case.

What's At Issue?

The on-sale bar holds that sales of an invention that...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!